GO
Loading...

Johnson & Johnson

More

  • Final Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 6:41 PM ET

    Baxter International Inc. rose$. 41 or. 6 percent, to $74.48. Bristol-Myers Squibb Co. rose$. 51 or. 8 percent, to $61.30. Hospira rose$. 22 or. 4 percent, to $62.66.

  • FDA approves AbbVie combo hepatitis C treatment Friday, 19 Dec 2014 | 3:35 PM ET

    TRENTON, N.J.— Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie. The Food and Drug Administration on Friday approved the sale of a packaged treatment called Viekira Pak made by AbbVie Inc. of North Chicago, Illinois. It includes a combination pill, which...

  • Midday Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 1:25 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $74.29. Bristol-Myers Squibb Co. rose$. 15 or. 2 percent, to $60.94. Hospira rose$. 18 or. 3 percent, to $62.62.

  • Midday Glance: Medical Devices companies Friday, 19 Dec 2014 | 1:25 PM ET

    Allergan rose $2.05 or 1.0 percent, to $214.23. Baxter International Inc. rose$. 22 or. 3 percent, to $74.29. Boston Scientific Corp. fell$. 06 or. 4 percent, to $13.21.

  • Early Glance: Pharmaceuticals companies Friday, 19 Dec 2014 | 10:20 AM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $73.57. Bristol-Myers Squibb Co. rose$. 27 or. 4 percent, to $61.06. Hospira fell$. 02 or percent, to $62.42.

  • Early Glance: Medical Devices companies Friday, 19 Dec 2014 | 10:20 AM ET

    Allergan rose $1.03 or. 5 percent, to $213.21. Baxter International Inc. fell$. 50 or. 7 percent, to $73.57. Boston Scientific Corp. fell$. 02 or. 2 percent, to $13.24.

  • GENEVA, Dec 19- Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information. Countries where the trials are planned-- Cameroon, Ghana, Mali, Nigeria and Senegal-- should receive and review the additional...

  • Final Glance: Medical Devices companies Thursday, 18 Dec 2014 | 8:09 PM ET

    Allergan rose $4.15 or 2.0 percent, to $212.18. Baxter International Inc. rose $1.80 or 2.5 percent, to $74.07. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Final Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 8:09 PM ET

    Baxter International Inc. rose $1.80 or 2.5 percent, to $74.07. Bristol-Myers Squibb Co. rose $1.60 or 2.7 percent, to $60.79. Hospira rose $2.19 or 3.6 percent, to $62.44.

  • Midday Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 1:48 PM ET

    Baxter International Inc. rose $1.12 or 1.5 percent, to $73.39. Bristol-Myers Squibb Co. rose $1.16 or 2.0 percent, to $60.35. Hospira rose $1.44 or 2.4 percent, to $61.69.

  • Midday Glance: Medical Devices companies Thursday, 18 Dec 2014 | 1:48 PM ET

    Allergan rose $3.93 or 1.9 percent, to $211.96. Baxter International Inc. rose $1.12 or 1.5 percent, to $73.39. Boston Scientific Corp. rose$. 16 or 1.2 percent, to $13.18.

  • Early Glance: Medical Devices companies Thursday, 18 Dec 2014 | 11:11 AM ET

    Allergan rose $3.56 or 1.7 percent, to $211.59. Baxter International Inc. rose$. 94 or 1.3 percent, to $73.21. Boston Scientific Corp. rose$. 20 or 1.5 percent, to $13.22.

  • Early Glance: Pharmaceuticals companies Thursday, 18 Dec 2014 | 11:11 AM ET

    Baxter International Inc. rose$. 94 or 1.3 percent, to $73.21. Bristol-Myers Squibb Co. rose$. 69 or 1.2 percent, to $59.88. Hospira rose$. 68 or 1.1 percent, to $60.93.

  • The watchdog announced sanctions totaling 345.2 million euros on cleaning products makers Colgate-Palmolive, Henkel, Unilever, Procter& Gamble, Reckitt Benckiser, Sara Lee, SC Johnson and Bolton Solitaire. It announced a further 605.9 million euros of fines relating to personal hygiene products against Colgate-Palmolive, Henkel, Unilever, Procter& Gamble,...

  • Dec 17- Oracle Corp reported a 3.5 percent increase in quarterly revenue on Wednesday, beating Wall Street's expectations, as sales at its closely watched cloud services business rose 45 percent. Investors have been carefully watching how Oracle beefs up its cloud divisions, which deliver software over the Internet. "Oracle has been going through a transition...

  • Final Glance: Medical Devices companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    Allergan rose $2.28 or 1.1 percent, to $208.03. Baxter International Inc. rose $1.54 or 2.2 percent, to $72.27. Boston Scientific Corp. rose$. 07 or. 5 percent, to $13.02.

  • Final Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    Baxter International Inc. rose $1.54 or 2.2 percent, to $72.27. Bristol-Myers Squibb Co. rose $1.50 or 2.6 percent, to $59.19. Hospira rose $1.43 or 2.4 percent, to $60.25.

  • Dec 17- Tetraphase Pharmaceuticals Inc said its antibiotic to treat complicated intra-abdominal infections was as effective as Merck& co Inc's ertapenem in a late-stage study. Tetraphase is also testing the drug against Johnson& Johnson's levofloxacin to treat complicated urinary tract infections in another late-stage study, the results of which are...

  • Midday Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 93 or 1.3 percent, to $71.66. Bristol-Myers Squibb Co. rose$. 65 or 1.1 percent, to $58.34. Hospira rose $1.11 or 1.9 percent, to $59.93.

  • Midday Glance: Medical Devices companies Wednesday, 17 Dec 2014 | 1:17 PM ET

    Allergan rose $1.74 or. 8 percent, to $207.49. Baxter International Inc. rose$. 93 or 1.3 percent, to $71.66. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.90.